Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
4.650
-0.080 (-1.69%)
Dec 3, 2025, 4:00 PM EST - Market closed
Genelux Market Cap
Genelux has a market cap or net worth of $174.93 million as of December 4, 2025. Its market cap has increased by 117.33% in one year.
Market Cap
174.93M
Enterprise Value
155.63M
1-Year Change
117.33%
Ranking
Category
Stock Price
$4.65
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has increased from $141.69M to $174.93M, an increase of 23.45%. That is a compound annual growth rate of 7.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 174.93M | 117.33% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 947.22B |
| Johnson & Johnson | 494.72B |
| AbbVie | 397.86B |
| UnitedHealth Group | 292.78B |
| AstraZeneca | 283.73B |
| Merck & Co. | 252.74B |
| Novartis AG | 249.18B |
| Abbott Laboratories | 222.59B |